Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q96G61
UPID:
NUD11_HUMAN
Alternative names:
Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-beta; Diadenosine hexaphosphate hydrolase (AMP-forming); Nucleoside diphosphate-linked moiety X motif 11; hAps1
Alternative UPACC:
Q96G61; Q9NVN0
Background:
Diphosphoinositol polyphosphate phosphohydrolase 3-beta, also known by alternative names such as Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-beta, plays a crucial role in signal transduction through its ability to cleave beta-phosphate from diphosphate groups in PP-InsP5. This enzyme also specializes in the hydrolysis of dinucleoside oligophosphates, with Ap6A and Ap5A as preferred substrates, leading to the production of ADP, p4a, and ATP.
Therapeutic significance:
Understanding the role of Diphosphoinositol polyphosphate phosphohydrolase 3-beta could open doors to potential therapeutic strategies.